In the recent study using the mice lacking Kdm6a in the urothelium, Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with p53 dysfunction [41]. This evidence concerns the gene TP53 and urinary bladder cancer.